돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 493349생성일: 2026년 10월 23일

Sodium Hydroxide → 1-(4-Chloro-[1,2,5]thiadiazol-3-yl)piperazine hydrochloride

https://huagongshe.com/ko/reaction/493349

반응식

참여 물질

역할이름HCID투입량
반응물Sodium HydroxideHCID 14798—
반응물3,4-Dichloro-1,2,5-thiadiazoleHCID 79804—
반응물Piperazine, hexahydrateHCID 120181—
용매DimethylformamideHCID 6228—
용매Sodium chloride; waterHCID 57417360—
생성물1-(4-Chloro-[1,2,5]thiadiazol-3-yl)piperazine hydrochlorideHCID 2120204289%

반응 조건

온도70 °C

반응 단계

A mixture of 3,4-dichloro-1,2,5-thiadiazole (4.00 g, 25.8 mmol) and piperazine hexahydrate (25.0 g, 130 mmol) in DMF (25 mL) was heated at 70° C. for 20 minutes. After cooling to ambient temperature, the reaction mixture was basified (11 M NaOH) and brine was added. The resulting mixture was extracted with CHCl3 (×3). The combined organic phases were washed twice with brine/water (1:1), dried (MgSO4) and the solvent was evaporated. The resulting oil was purified by column chromatography on silica gel using CHCl3 as eluent to give 2.77 g (52%) of the title compound as a colourless oil which was converted to its hydrochloride salt: mp 231° C. (dec). Anal (C6H9ClN4S.HCl), C calc 29.89, found 30.4. H. N

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07534794B2
출처 데이터셋uspto-grants-2009_05
ORD IDord-3bec647fc2294116bc60f4351f38de2b
출처 메모uspto-grants-2009_05